相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Impacts of Fish Oil and/or Probiotic Intervention on Low-Grade Inflammation, IGFBP-1 and MMP-8 in Pregnancy: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Noora Houttu et al.
BIOMOLECULES (2021)
Role of Medium-Chain Fatty Acids in Healthy Metabolism: A Clinical Perspective
Lili Huang et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2021)
Combined prenatal Lactobacillus reuteri and ω-3 supplementation synergistically modulates DNA methylation in neonatal T helper cells
Johanna Huoman et al.
CLINICAL EPIGENETICS (2021)
GlycA, a novel marker for low grade inflammation, reflects gut microbiome diversity and is more accurate than high sensitive CRP in reflecting metabolomic profile
Kati Mokkala et al.
METABOLOMICS (2020)
Distinct Metabolomic Profile Because of Gestational Diabetes and its Treatment Mode in Women with Overweight and Obesity
Kati Mokkala et al.
OBESITY (2020)
Circulating cathepsin B and D in pregnancy
Ho Yeon Kim et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2019)
Efficacy of Fish Oil and/or Probiotic Intervention on the Incidence of Gestational Diabetes Mellitus in an At-Risk Group of Overweight and Obese Women: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Outi Pellonpera et al.
DIABETES CARE (2019)
Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis
Aikaterini Lavrentaki et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2019)
Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
Meng-Wei Xiao et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2019)
A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial
Nazarii Kobyliak et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2018)
Triggering and resolution of inflammation in NASH
Susanne Schuster et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease
Kathy Musa-Veloso et al.
NUTRITION REVIEWS (2018)
Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study
Nazarii Kobyliak et al.
MINERVA MEDICA (2018)
Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference
Signe Foghsgaard et al.
DIABETES CARE (2017)
Metabolic Profiling of Fatty Liver in Young and Middle-Aged Adults: Cross-Sectional and Prospective Analyses of the Young Finns Study
Jari E. Kaikkonen et al.
HEPATOLOGY (2017)
GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
Margery A. Connelly et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease
Veeral H. Ajmera et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention
Sofie M. A. Walenbergh et al.
SCIENTIFIC REPORTS (2016)
Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic Infl ammation
Sofie M. A. Walenbergh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
Pasi Soininen et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation
James D. Otvos et al.
CLINICAL CHEMISTRY (2015)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics
Pasi Soininen et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial
Yu Qin et al.
PLOS ONE (2015)
Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
Tannaz Eslamparast et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Cathepsin D levels are reduced in patients with preeclampsia in Korean population
Ho Yeon Kim et al.
CLINICAL BIOCHEMISTRY (2013)
Localization of Cathepsins D and B at the Maternal-Fetal Interface and the Invasiveness of the Trophoblast during the Postimplantation Period in the Mouse
A. M. Amarante-Paffaro et al.
CELLS TISSUES ORGANS (2011)
Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes
S. Forbes et al.
DIABETOLOGIA (2011)
Cathepsins B and D Drive Hepatic Stellate Cell Proliferation and Promote Their Fibrogenic Potential
Anna Moles et al.
HEPATOLOGY (2009)
Vascular Endothelial Function and Leisure-Time Physical Activity in Adolescents
Katja Pahkala et al.
CIRCULATION (2008)
分享论文
